• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于基因集改变的新型分类方法可预测骨肉瘤的预后和药物敏感性。

A novel classification predicts prognosis and drug sensitivity in osteosarcoma based on alterations in gene sets.

机构信息

Department of Spine Surgery, Ganzhou People’s Hospital, Ganzhou, Jiangxi, China.

出版信息

Aging (Albany NY). 2024 Feb 28;16(5):4579-4590. doi: 10.18632/aging.205614.

DOI:10.18632/aging.205614
PMID:38428404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10968677/
Abstract

Osteosarcoma is a cancer originating in the bone cells, specifically in the osteoblasts. Previous studies mainly focused on particular molecules but the whole pathway network. We comprehensively analyzed the enrichment score of each signal pathway and identified a novel classification by 20 machine learning algorithms. Furthermore, differences in tumor immune infiltration cells and drug sensitivity were compared in low and high groups. We identified a model consisting of four signaling pathways that predict the prognosis and the immune status of the tumor microenvironment and drug sensitivity in osteosarcoma patients. The novel classification may be used in clinical applications to predict prognosis and drug sensitivity.

摘要

骨肉瘤是一种起源于骨细胞的癌症,特别是成骨细胞。之前的研究主要集中在特定的分子上,但我们全面分析了每条信号通路的富集评分,并通过 20 种机器学习算法确定了一种新的分类。此外,我们还比较了低分组和高分组肿瘤免疫浸润细胞和药物敏感性的差异。我们确定了一个由四个信号通路组成的模型,该模型可以预测骨肉瘤患者的预后和肿瘤微环境的免疫状态以及药物敏感性。这种新的分类方法可能会用于临床应用,以预测预后和药物敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/664dec90be8b/aging-16-205614-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/55928889fcdf/aging-16-205614-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/75bdde9ae7da/aging-16-205614-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/665b7ddd1122/aging-16-205614-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/17b071e92b45/aging-16-205614-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/78adce0aae68/aging-16-205614-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/664dec90be8b/aging-16-205614-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/55928889fcdf/aging-16-205614-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/75bdde9ae7da/aging-16-205614-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/665b7ddd1122/aging-16-205614-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/17b071e92b45/aging-16-205614-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/78adce0aae68/aging-16-205614-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/10968677/664dec90be8b/aging-16-205614-g006.jpg

相似文献

1
A novel classification predicts prognosis and drug sensitivity in osteosarcoma based on alterations in gene sets.一种基于基因集改变的新型分类方法可预测骨肉瘤的预后和药物敏感性。
Aging (Albany NY). 2024 Feb 28;16(5):4579-4590. doi: 10.18632/aging.205614.
2
The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.肿瘤免疫微环境和免疫相关特征可预测骨肉瘤患者的化疗反应。
BMC Cancer. 2021 May 21;21(1):581. doi: 10.1186/s12885-021-08328-z.
3
A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.骨肉瘤肿瘤微环境中免疫浸润的综合分析。
Cancer Med. 2021 Aug;10(16):5696-5711. doi: 10.1002/cam4.4117. Epub 2021 Jul 13.
4
A CIC-related-epigenetic factors-based model associated with prediction, the tumor microenvironment and drug sensitivity in osteosarcoma.一个与预测、肿瘤微环境和骨肉瘤药物敏感性相关的 CIC 相关表观遗传因子模型。
Sci Rep. 2024 Jan 15;14(1):1308. doi: 10.1038/s41598-023-49770-2.
5
Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.鉴定和特征分析骨肉瘤中与衰老/衰老相关的基因,并预测临床预后。
Front Immunol. 2022 Oct 5;13:997765. doi: 10.3389/fimmu.2022.997765. eCollection 2022.
6
The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.己糖胺生物合成途径相关基因特征与免疫浸润相关,并可预测骨肉瘤患者的预后。
Front Immunol. 2022 Oct 6;13:1028263. doi: 10.3389/fimmu.2022.1028263. eCollection 2022.
7
The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma.线粒体能量代谢途径相关特征可预测骨肉瘤的预后,并提示免疫微环境浸润。
Medicine (Baltimore). 2023 Nov 17;102(46):e36046. doi: 10.1097/MD.0000000000036046.
8
Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.骨肉瘤肿瘤微环境中免疫细胞浸润和免疫相关基因的特征。
BMC Cancer. 2021 Dec 18;21(1):1345. doi: 10.1186/s12885-021-09042-6.
9
System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy.基于凋亡相关基因的系统分析鉴定 MAPK1 为新辅助化疗骨肉瘤的治疗靶点。
BMC Musculoskelet Disord. 2024 Jun 4;25(1):437. doi: 10.1186/s12891-024-07547-2.
10
A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.一种预测骨肉瘤预后和指导治疗的新型免疫细胞特征。
Front Immunol. 2022 Sep 14;13:1017120. doi: 10.3389/fimmu.2022.1017120. eCollection 2022.

本文引用的文献

1
IL-7: Comprehensive review.白细胞介素-7:全面综述。
Cytokine. 2022 Dec;160:156049. doi: 10.1016/j.cyto.2022.156049. Epub 2022 Oct 3.
2
Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis.检测和监测骨肉瘤中的循环肿瘤细胞,以预测治疗反应和预后。
Cancer Biol Med. 2022 Sep 23;19(9):1397-409. doi: 10.20892/j.issn.2095-3941.2022.0279.
3
Osteosarcoma: A Surveillance, Epidemiology, and End Results program-based analysis from 1975 to 2017.骨肉瘤:1975 年至 2017 年基于监测、流行病学和最终结果计划的分析。
Cancer. 2022 Jun 1;128(11):2107-2118. doi: 10.1002/cncr.34163. Epub 2022 Feb 28.
4
New Horizons in the Treatment of Osteosarcoma.骨肉瘤治疗的新视野
N Engl J Med. 2021 Nov 25;385(22):2066-2076. doi: 10.1056/NEJMra2103423.
5
IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.IOBR:多组学免疫肿瘤生物学研究解码肿瘤微环境和特征。
Front Immunol. 2021 Jul 2;12:687975. doi: 10.3389/fimmu.2021.687975. eCollection 2021.
6
Interleukin (IL)-7 Signaling in the Tumor Microenvironment.肿瘤微环境中的白细胞介素 (IL)-7 信号通路
Adv Exp Med Biol. 2021;1290:9-49. doi: 10.1007/978-3-030-55617-4_2.
7
MicroRNA-150-5p inhibits proliferation and invasion of osteosarcoma cells by down-regulating VEGFA.miRNA-150-5p 通过下调 VEGFA 抑制骨肉瘤细胞的增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9265-9273. doi: 10.26355/eurrev_202009_23008.
8
Wnt signaling and Loxl2 promote aggressive osteosarcoma.Wnt 信号通路和 Loxl2 促进骨肉瘤的侵袭转移。
Cell Res. 2020 Oct;30(10):885-901. doi: 10.1038/s41422-020-0370-1. Epub 2020 Jul 20.
9
Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights.帕唑帕尼和曲美替尼联合治疗骨肉瘤的协同策略:临床前活性及分子机制研究
Cancers (Basel). 2020 Jun 10;12(6):1519. doi: 10.3390/cancers12061519.
10
Using Liquid Biopsy in the Treatment of Patient with OS.液体活检在 OS 患者治疗中的应用。
Adv Exp Med Biol. 2020;1257:95-105. doi: 10.1007/978-3-030-43032-0_9.